May 13, 2026 08:00AM
Apr 17, 2026 08:00AM
Apr 17, 2026 08:00AM
Mar 2, 2026 04:05PM
Dec 22, 2025 07:06AM
Dec 1, 2025 08:02AM
Dec 1, 2025 08:00AM Tyra Biosciences Strengthens Leadership Team with Appointments of Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer
Nov 5, 2025 04:05PM
Aug 21, 2025 08:00AM
Aug 21, 2025 08:00AM
Aug 14, 2025 04:05PM
Jun 30, 2025 08:00AM
May 8, 2025 04:05PM
Mar 27, 2025 04:05PM Tyra Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights
Jan 29, 2025 04:06PM
Jan 29, 2025 04:05PM
Jan 22, 2025 08:00AM
Jan 10, 2025 08:06AM
Jan 10, 2025 08:00AM
Jan 2, 2025 12:51PM
Nov 7, 2024 04:05PM Tyra Biosciences Reports Third Quarter 2024 Financial Results and Highlights
Oct 28, 2024 10:42AM
Oct 28, 2024 07:00AM
Oct 28, 2024 07:00AM
Oct 24, 2024 06:21PM
Sep 10, 2024 04:05PM
Sep 10, 2024 04:05PM
Aug 7, 2024 04:05PM Tyra Biosciences Reports Second Quarter 2024 Financial Results and Highlights
Jul 2, 2024 04:05PM
Jul 2, 2024 04:05PM
May 9, 2024 04:05PM
May 7, 2024 04:06PM
May 7, 2024 04:05PM
Mar 19, 2024 04:05PM
Feb 1, 2024 05:30PM Tyra Biosciences (TYRA) Receives FDA Rare Pediatric Disease Designation for TYRA-300
Feb 1, 2024 05:30PM
Dec 22, 2023 09:00AM
Nov 7, 2023 04:05PM
Aug 10, 2023 04:05PM
Aug 1, 2023 08:02AM
Aug 1, 2023 08:00AM
May 4, 2023 04:05PM Tyra Biosciences Reports First Quarter 2023 Financial Results and Highlights
Mar 22, 2023 04:05PM
Mar 1, 2023 07:02AM
Mar 1, 2023 07:00AM
Nov 3, 2022 04:05PM
Nov 2, 2022 04:09PM
Nov 2, 2022 04:05PM
Sep 5, 2022 08:15AM Tyra Biosciences to Present Preclinical Data on TYRA-300, an FGFR3-selective Inhibitor, at ESMO 2022 Congress
Aug 4, 2022 04:05PM

323,580 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All